SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-18-356779
Filing Date
2018-12-24
Accepted
2018-12-21 21:11:55
Documents
2
Group Members
PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d677789dsc13g.htm SC 13G 62306
2 EXHIBIT 1 d677789dex991.htm EX-99.1 7415
  Complete submission text file 0001193125-18-356779.txt   71727
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Subject) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90503 | Film No.: 181251096
SIC: 2834 Pharmaceutical Preparations

Mailing Address CODAN TRUST COMPANY (CAYMAN) LIMITED CRICKET SQ., HUTCHINS DR., GEORGE TOWN GRAND CAYMAN E9 KY1-1111
Business Address CODAN TRUST COMPANY (CAYMAN) LIMITED CRICKET SQ., HUTCHINS DR., GEORGE TOWN GRAND CAYMAN E9 KY1-1111 (345) 949 1040
Pivotal bioVenture Partners Fund I, L.P. (Filed by) CIK: 0001695076 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13G